CBD reduces COVID-19 lung damage with protective peptides
In a new study, scientists have shown that one of the non-psychoactive cannabinoids in cannabis – CBD – reduces lung damage induced by cytokine...
Clinical trial shows potential of cannabis to lessen sickle cell disease pain
In a first of its kind clinical trial using gold-standard methods, cannabis has been shown to mitigate the pain of sickle cell disease.
People who...
Project Twenty21: Europe’s largest medical cannabis registry goes live
Drug Science’s Project Twenty21, Europe’s largest medical cannabis patient registry, has gone live today, registering its first patient for a medical cannabis prescription.
The Project...
Advocacy group launches Australian Medicinal Cannabis Course Online
The recent Senate recommendations to substantially increase medical cannabis education for health professionals are being implemented by a leading advocacy group with the launch...
Formation of the Society of Cannabis Clinicians UK Chapter
The Society of Cannabis Clinicians (SCC) is partnering with the Sapphire Institute for Medical Cannabis Education to form the SCC UK Chapter.
SCC is a...
Evidence CBD may reduce cytokine storm and inflammation in COVID-19
A new study has revealed early evidence that CBD may help to reduce cytokine storms and excessive lung inflammation in patients with COVID-19.
Carried out...
Cannabis research, innovation, and policy in Australia
Professor Jennifer Martin, Chair of Clinical Pharmacology at the University of Newcastle and Director of the Australia Centre for Cannabinoid Clinical and Research Excellence,...
The Center for Medicinal Cannabis Research with Dr Igor Grant
In this article, Dr Igor Grant explores the work of the Center for Medicinal Cannabis Research.
When the Center for Medicinal Cannabis Research at UC...
Cannabis medicine, education, and policy in Switzerland
Professor Rudolf Brenneisen of the Swiss Society of Cannabis in Medicine tells us about medical cannabis in Switzerland.
The Swiss Society of Cannabis in Medicine...
Cannaponics: cultivation and revitalisation in Western Australia
“This movement is more than just a phenomenon, it is a necessity. At Cannaponics Limited we are committed to leading a movement, not just...
Medical cannabis patients use fewer healthcare resources
A new study has revealed that medical cannabis patients use fewer healthcare resources and report improved quality of life.
To date, there has been minimal...
Leafcann Group: how do we futureproof the medicinal cannabis industry?
Leafcann Group CEO Elisabetta Faenza explores regulatory reform, best practice standards and the future of the medicinal cannabis market.
Many industries around the world are...
Cannabis concentrates boost THC blood levels but do not get you ‘higher’
A new study has shown that cannabis concentrates do increase THC levels in the blood, but do not actually have a stronger psychoactive impact...
Evidence still unclear on whether cannabis affects risk of stroke
Whether cannabis increases a person’s risk of suffering a stroke is still unclear. A new study explored whether there was a connection between recent...
Oaksterdam University: cannabis legalisation, education and civil rights
Cannabis campaigner and Oaksterdam University President Dale Sky Jones talks to MCN about cannabis legalisation, education and civil rights.
Dale Sky Jones led the 2010...
Research and regulation in Canada with the CCIC
Canadian Consortium for the Investigation of Cannabinoids (CCIC) Deputy Director Dr Lynda Balneaves speaks to MCN about education, research and patient safety.
The Canadian Consortium...
Cannabis, neuropsychiatry and education with Dr Ilya Reznik
Dr Ilya Reznik discusses the use of cannabinoid-based medicines for neuropsychiatric disorders and the barriers to prescribing CBD.
Dr Ilya Reznik has published many original...
Wholly Hemp: putting phytocannabinoids in focus
Wholly Hemp INC/Cannabidiol Life Brands, showcases the history and future of phytocannabinoid research in the USA and worldwide.
In this article Jessica Arent, Chief Compliance...
New study to look at impact of COVID-19 on cannabis patients
A new study will be looking at the impact of the novel coronavirus – COVID-19 – on patients who use medical cannabis.
A preliminary study...
Khiron launches online cannabis course with Latin American university
A new, online cannabis course has been launched by Khiron Life Sciences in conjunction with Latin American University – Tecnologico de Monterrey.
Cannabis company, Khiron...
